Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome

Clinical Autonomic Research

Volumn 7, Issue 4, 1997, Pages 185-190

  De Lorenzo, F ^a   Hargreaves, J ^a   Kakkar, V V ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Chronic fatigue syndrome; Orthostatic hypotension; Postural tachycardia syndrome resin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; RENIN; SLOW SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; PATIENT CARE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUSTAINED RELEASE PREPARATION; TILTING;

ADULT; CATECHOLAMINES; DELAYED-ACTION PREPARATIONS; FATIGUE SYNDROME, CHRONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; POSTURE; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE; VASOPRESSINS;

EID: 0030812185     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02267980     Document Type: Article

References (31)

1. McKenzie R, Straus ES. Chronic fatigue syndrome. Adv Int Med 1995; 40: 119-153.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-959.
3. Holmes GP, Kaplan JE, Gantz NM et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387-389.
4. Bou-Holaigah I, Rowe CP, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274: 961-967.
5. DeLorenzo F, Hargreaves J, Kakkar VV. Possible relationship between chronic fatigue syndrome and postural tachycardia syndromes. Clin Auton Res 1996; 6: 263-264.
6. Rowe CP, Bou-Holaigah I, Kan JS, Calkins J. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995; 345: 623-624.
7. Kaufman H. Neurally mediated syncope: pathogenesis, diagnosis, and treatment. Neurology 1995; 45(suppl. 5): 512-518.
8. Low AP, Opfer-Gehrking TL, Textor CS et al. Postural tachycardia syndrome (POTS). Neurology 1995; 45: S19-S25.
9. Fouad FM, Tadena Thome L, Bravo EL et al. Idiopathic hypovolemia. Ann Intern Med 1986; 104: 298-303.
10. Rosen SG, Cryer PE. Postural tachycardia syndrome: reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading. Am J Med 1982; 72: 847-850.
11. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993; 43: 132-137.
12. Polinsky RJ, Kopin IJ, Ebert MH et al. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 1981; 31: 1-7.
13. Grubb BP, Temsey-Armos P, Hahn H et al. Utility of upright tilt table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991; 90: 6-10.
14. Strasberg B, Rechavia E, Sagie A et al. The head up tilt table test in patients with syncope of unknown origin. Am Heart J 1989; 118: 923-927.
15. Almquist A, Goldenberger IF, Nilstein S et al. Provocation of bradycardia and hypotension by isoprotenerol and upright posture in patients with unexplained syncope. N Engl J Med 1989; 320: 346-351.
16. Sra JS, Anderson SJ, Sheik SH et al. Unexplained syncope evaluated by electrophysiologic studies and head up tilt testing. Ann Int Med 1991; 114: 1013-1019.
17. Sheldon R, Killam S. Methodology of isoprotenerol tilt table testing in patients with syncope. J Am Coll Cardiol 1992; 19: 773-779.
18. Waxman MB, Yao L, Cameron DA et al. Isoprotenerol induction of vasodepressor type reaction in vasodepressor persons. Am J Cardiol 1989; 63: 58-65.
19. Chen XC, Chen MY, Remole S et al. Reproducibility of head up tilt table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 1992; 69: 755-760.
20. Grubb BP, Wolfe D, Temesy Armos P et al. Reproducibility of head up-right tilt table results in patients with syncope. Pacing Clin Electrophysiol 1992; 15: 1477-1481.
21. Fisk JD, Ritvo PG, Ross L, Haase DA, Marie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Disease 1994; 18(suppl. 1): S79-83.
22. Savage DD, Corwin L, McGee DL et al. Epidemiological features of isolated syncope: The Framingham Study. Stroke 1985; 16: 626-629.
23. Day SC, Cook EF, Funkenstein GH et al. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982; 73: 15-23.
24. Oribe E, Kaufamnn H, Winters S et al. Fludrocortisone versus beta-adrenergic blockers in the treatment of vasovagal syncope [abstract]. Neurology 1992; 42(3): 213.
25. Thames MD. Effect of d- and I-propranolol on the discharge of cardiac vagal C fibres. Am J Physiol 1980; 238: H465-470.
26. Strieper MJ, Campbell R. Efficacy of alpha-adrenergic agonist therapy for the prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol 1993; 22: 594-597.
27. McLaren CJ, Gersh BJ, Osborn MJ et al. Increased vagal tone as an isolated finding in patients undergoing electrophysiological testing for recurrent syncope: response to long term anticholinergic agents. Br Heart J 1986; 55: 53-57.
28. De Lorenzo F, Kakkar VV. Twenty-four hour urine analysis in patients with orthostatic hypotension and chronic fatigue syndrome (CFS). Aust NZ J Med 1996; 26: 849-850.
29. Mathias CJ, May CN, Taylor GM. The renin angiotensin system and hypertension - basic and clinical aspects. In: Malcolm ADB, ed. Molecular Medicine, Vol. 1. Oxford: IRL Press, 1984; 177-208.
30. Mathias CJ, Frankel HL, Davies IB et al. Renin and aldosterone release during sympathetic stimulation in tetraplegia. Clin Sci 1981; 60: 399-404.
31. Williams GH, Dluhy RG. Control of aldosterone secretion. In: Genest J et al., eds. Hypertension, 2nd edn. New York: McGraw-Hill, 1983; 320.